India's GlaxoSmithKline Pharma jumps on Q4 profit rise
** Shares of GlaxoSmithKline Pharmaceuticals GLAX.NS up 7.1%
to 142.3 rupees, its highest since late Feb.
** Healthcare firm's Q4 consol profit jumps ~46% y/y to 1.94
bln rupees, rev from ops up 18%
** Stock was down 0.1% ahead of results
** GLAX is up about 16.3% this week so far, on course for
highest weekly gains
** Including session's gains, GLAX is up 22% YTD
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees